BIOTechNZ News
Annual Meeting Presentation
For those members who were unable to join us for the Annual Meeting on 21st July 2020, you can view the meeting presentation here.
July 22, 2020
Annual Meeting Presentation
22 July 2020
For those members who were unable to join us for the Annual Meeting on 21st July 2020, you can view the meeting presentation here.
Read More
The precautionary principle
03 July 2020
The Precautionary Principle, there are many definitions, but the most common expression today claims that a practice, substance or technology must be banned or prohibited if it cannot be proven (with certainty) to be safe. R
Read More
Congratulations to our dames and knights and our ongoing fight
03 June 2020
Congratulations to our Neonatal expert Professor Jane Harding as she is now one of the Dame Companions of the New Zealand Order of Merit (NZOM). Congratulations also to medical researcher Professor Robert Elliott who has been appointed Knight Companions of the NZOM.
Read More
New Zealand biotech firm tackling COVID-19 and M. bovis
18 May 2020
Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis.
Read More BIOTechNZ News
The precautionary principle
The Precautionary Principle, there are many definitions, but the most common expression today claims that a practice, substance or technology must be banned or prohibited if it cannot be proven (with certainty) to be safe. Rather than trying to reduce exposure to risks or solve problems with innova
July 3, 2020
BIOTechNZ News
Congratulations to our dames and knights and our ongoing fight
Congratulations to our Neonatal expert Professor Jane Harding as she is now one of the Dame Companions of the New Zealand Order of Merit (NZOM). Congratulations also to medical researcher Professor Robert Elliott who has been appointed Knight Companions of the NZOM. Well deserved recog
June 3, 2020
Media Release
New Zealand biotech firm tackling COVID-19 and M. bovis
Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis. Pictor has received a grant of $500,000 from the $25 million MBIE COVID-19 Innovation Acceleration Fund,
May 18, 2020
Media Release
Initial funding opens doors for national vaccine strategy
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
May 8, 2020
BIOTechNZ News
COVID-19: The massive social and economic experiment
Currently, an estimated 2.6 billion people – one-third of the world’s population – are living under some kind of lockdown or quarantine. This is arguably the largest social and economic experiment ever conducted. There are lots of coronavirus memes on the internet, however,&
May 6, 2020
Industry News
Top scientists call for urgent COVID vaccine strategy to ensure New Zealand’s health and economic viability
Some of New Zealand’s top scientists are urging the need for a national COVID-19 vaccine programme to ensure New Zealand is best placed to access an effective vaccine at the earliest opportunity. Malaghan Institute Director Professor Graham Le Gros and University of Otago’s Professor Miguel
April 15, 2020
BIOTechNZ News
Stay home. It WILL save lives
Hi, We’re facing new and fast-moving challenges and opportunities. For most of you this will mean your day to day work will continue, albeit in very different working environments. A significant number of our biotech companies are defined as essential services. If you believe yo
April 2, 2020
BIOTechNZ News
Major medicinal cannabis summit postponed
“We have made the difficult decision to postpone the MedCan Summit 2020 this week. However, we remain firmly committed to hosting New Zealand’s first medicinal cannabis summit later this year, as the future of large events and international travel becomes clear,” says Dr Zahra Champion, Execu
March 17, 2020